Skip to content
Logo UroCCR fond blanc

News

Resources

Database
  • French
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
Contact

News

Resources

Database
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
  • The Network
    • Presentation
    • Governance
  • Research projects
  • Medical devices
    • Presentation
    • Governance
  • UroPredict AI
  • Partners
  • Contact
  • News
  • Resources
  • Database
Contact

Phase: Finished

Oncocytoma on renal mass biopsy: what next?

Outcomes of minimally invasive conservative treatments of Oncocytoma: Percutaneous Ablation vs Robotic Partial Nephrectomy.

Results of minimally invasive conservative treatments for cT1a renal carcinoma on kidney transplants: percutaneous ablation vs. robotic partial nephrectomy.

Effectiveness of robot-assisted partial nephrectomy using augmented reality for complex kidney tumors. Randomized controlled trial of CCAFU-UROCCR.

Results of minimally invasive conservative treatments for cT1a renal carcinoma in patients over 80 years of age: percutaneous ablation vs. robotic partial nephrectomy

Impact of positive surgical margins on short-term oncological prognosis after robot-assisted partial nephrectomy.

Impact of selective embolization of tumor vessels on renal function after partial nephrectomy in a hybrid operating room.

Evaluation of the use of the hybrid operating room on renal cancer surgery activity.

External validation of the SPARE (Simplified PADUA REnal) score to assess perioperative morbidity in robot-assisted partial nephrectomy: A French multicenter retrospective study.

Evaluation du taux sérique des protéines de la famille des sémaphorines pour l’identification d’un biomarqueur du carcinome rénal.

← Previous
Next →
Cercle rouge UroCCR Bordeaux
Cercle bleu UroCCR Bordeaux
Logo UroCCR
  • Address

Department of Urology
Bordeaux University Hospital Centre
Place Amélie Raba-Léon 33076 Bordeaux cedex

  • Telephone │+33 05 57 82 12 94
  • E-MAIL │uroccr@chu-bordeaux.fr
  • FAX │+33 05 56 79 56 51
Linkedin-in Youtube X-twitter

Legal notices

Privacy policy

Copyright © 2026 UroCCR
  • French